Back to User profile » Dr Marco Lanza

Papers published by Dr Marco Lanza:


Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis

Comi E, Lanza M, Ferrari F, Mauri V, Caselli G, Rovati LC

Journal of Pain Research 2017, 10:1033-1043

Published Date: 4 May 2017

CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats

Meregalli C, Ceresa C, Canta A, Carozzi VA, Chiorazzi A, Sala B, Oggioni N, Lanza M, Letari O, Ferrari F, Avezza F, Marmiroli P, Caselli GF, Cavaletti G

Journal of Pain Research 2012, 5:151-167

Published Date: 20 June 2012

Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain

Ferrari F, Fiorentino S, Mennuni L, Garofalo P, Letari O, Mandelli S, Giordani A, Lanza M, Caselli G

Journal of Pain Research 2011, 4:111-125

Published Date: 18 April 2011